trending Market Intelligence /marketintelligence/en/news-insights/trending/Grq3zVYQISEabL8QxMl7zw2 content esgSubNav
In This List

Kindred Biosciences plans common stock offering

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Kindred Biosciences plans common stock offering

Kindred Biosciences Inc. is looking to raise funds for its product pipeline via an underwritten public offering that is yet to be priced.

The San Francisco-based biotechnology company, which is developing medicines for pets, has engaged Barclays Capital Inc. and Stifel as joint book-running managers. The underwriters will have an option to buy additional shares from the company.